Skip to main content

Table 1 Distribution of HER2 amplification results in ovarian tumours from BRCA1 and BRCA2 carriers and non-carriers

From: HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

HER2 amplification status BRCA1 BRCA2 Non-carriers
  n (%) n (%) n (%)
high amplification 2 (11) 2 (100) 2 (6)
low and moderate amplification 2 (11) 0 2 (6)
total amplified 4 (22) 2 (100) 4 (12)
no amplification 14 (78) 0 29 (88)
total 18 2 33